Nombre del producto:5-Bromo-2-(trifluoromethoxy)aniline

IUPAC Name:5-bromo-2-(trifluoromethoxy)aniline

CAS:886762-08-9
Fórmula molecular:C7H5BrF3NO
Pureza:98%
Número de catálogo:CM118425
Peso molecular:256.02

Unidad de embalaje Stock disponible Precio($) Cantidad
CM118425-100g in stock Əƞ
CM118425-500g in stock ŔŔǕ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :886762-08-9
Fórmula molecular:C7H5BrF3NO
Punto de fusión:-
Código de sonrisas:NC1=CC(Br)=CC=C1OC(F)(F)F
Densidad:
Número de catálogo:CM118425
Peso molecular:256.02
Punto de ebullición:230.2°C at 760 mmHg
Nº Mdl:MFCD04039242
Almacenamiento:Keep in dark place, store at 2-8°C.

Column Infos

Onvansertib
Polo-like kinase 1 (PLK1) is a key regulator of the cell-cycle progression found in human cancers, and a potential therapeutic target for oncology drug development. The recent journal Clinical Cancer Research details the Phase 1b Study of Onvansertib in combination with chemotherapy+bevacizumab treatment for patients with patients with KRAS-mutated metastatic colorectal cancer (mCRC).
Cardiff Oncology’s novel inhibitor, Onvansertib effectively targets PLK1, that prevents from tumor cell growth. It aids restore DNA damage and promote the efficacy of the standard of care therapy in a number of indications.

Related Products